Want to see MET full AI Analyst Report?

Metlife (MET) Stock Forecast & Price Target

2,972 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

MET Analyst Ratings

Strong Buy

10 Buy

2 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Metlife

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

MET Stock 12 Month Forecast

Average Price Target

$101.40

▲(6.93% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Metlife in the last 3 months. The average price target is $101.40 with a high forecast of $106.00 and a low forecast of $90.00. The average price target represents a 6.93% change from the last price of $94.83.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"69":"$69","88":"$88","107":"$107","78.5":"$78.5","97.5":"$97.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":106,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$106.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":101.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$101.40</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":90,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$90.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[69,78.5,88,97.5,107],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,87.2,88.64615384615385,90.0923076923077,91.53846153846155,92.98461538461538,94.43076923076923,95.87692307692308,97.32307692307693,98.76923076923077,100.21538461538462,101.66153846153847,103.1076923076923,104.55384615384615,{"y":106,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,87.2,88.2923076923077,89.38461538461539,90.47692307692309,91.56923076923077,92.66153846153847,93.75384615384615,94.84615384615385,95.93846153846154,97.03076923076924,98.12307692307692,99.21538461538462,100.3076923076923,{"y":101.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,87.2,87.41538461538462,87.63076923076923,87.84615384615385,88.06153846153846,88.27692307692308,88.49230769230769,88.70769230769231,88.92307692307692,89.13846153846154,89.35384615384615,89.56923076923077,89.78461538461538,{"y":90,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":78.727,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.853,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.593,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.151,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.086,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.191,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.783,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.66,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72.683,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 29, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.629,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.62,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.84,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.2,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$106.00

Average Price Target$101.40

Lowest Price Target$90.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Andrew Kligerman

TD Cowen

$87→$105

Buy

10.72%

Upside

Reiterated

07/22/26

MetLife price target raised to $105 from $87 at TD CowenMetLife price target raised to $105 from $87 at TD Cowen

Pablo Singzon

J.P. Morgan

$96→$106

Buy

11.78%

Upside

Reiterated

07/21/26

MetLife price target raised to $106 from $96 at JPMorganMetLife price target raised to $106 from $96 at JPMorgan

Joshua Shanker

Bank of America Securities

―

Buy

―

Reiterated

07/15/26

Analysts Offer Insights on Financial Companies: American Express (NYSE: AXP) and Metlife (NYSE: MET)

Yaron Kinar

Mizuho Securities

$102

Buy

7.56%

Upside

Reiterated

07/13/26

Mizuho Securities Remains a Buy on Metlife (MET)

Ryan Krueger

KBW

$98→$105

Buy

10.72%

Upside

Reiterated

07/12/26

MetLife price target raised to $105 from $98 at Keefe BruyetteMetLife price target raised to $105 from $98 at Keefe Bruyette

Suneet Kamath

Jefferies

$103

Buy

8.62%

Upside

Reiterated

07/09/26

Jefferies Sticks to Its Buy Rating for Metlife (MET)

Elyse Greenspan

Wells Fargo

$95→$101

Buy

6.51%

Upside

Reiterated

07/09/26

Analysts' Opinions Are Mixed on These Financial Stocks: Nasdaq (NASDAQ: NDAQ), Saratoga Investment (NYSE: SAR) and Metlife (NYSE: MET)

Michael Ward CFA

UBS

$102→$105

Buy

10.72%

Upside

Assigned

07/08/26

UBS Sticks to Its Buy Rating for Metlife (MET)

Alex Scott

Barclays

$93→$94

Buy

-0.88%

Downside

Reiterated

07/07/26

Barclays Sticks to Their Buy Rating for Metlife (MET)

Bob Huang

Morgan Stanley

$93→$103

Buy

8.62%

Upside

Reiterated

07/06/26

MetLife price target raised to $103 from $93 at Morgan StanleyMetLife price target raised to $103 from $93 at Morgan Stanley

Unknown Analyst

Raymond James

Not Ranked

Raymond James

―

Hold

―

Reiterated

06/30/26

Metlife (MET) Receives a Hold from Raymond James

Paul Newsome

Piper Sandler

$86→$90

Hold

-5.09%

Downside

Reiterated

06/24/26

Metlife (MET) Gets a Hold from Piper Sandler

Thomas Gallagher

Evercore ISI

$95→$96

Hold

1.23%

Upside

Reiterated

04/09/26

MetLife price target raised to $96 from $95 at Evercore ISIMetLife price target raised to $96 from $95 at Evercore ISI

Kevin Heal

Argus Research

$90

Buy

-5.09%

Downside

Reiterated

12/08/25

MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus

Jack Matten

BMO Capital

$82→$84

Hold

-11.42%

Downside

Reiterated

09/30/25

BMO Capital Keeps Their Hold Rating on Metlife (MET)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Andrew Kligerman

TD Cowen

$87→$105

Buy

10.72%

Upside

Reiterated

07/22/26

MetLife price target raised to $105 from $87 at TD CowenMetLife price target raised to $105 from $87 at TD Cowen

Pablo Singzon

J.P. Morgan

$96→$106

Buy

11.78%

Upside

Reiterated

07/21/26

MetLife price target raised to $106 from $96 at JPMorganMetLife price target raised to $106 from $96 at JPMorgan

Joshua Shanker

Bank of America Securities

―

Buy

―

Reiterated

07/15/26

Analysts Offer Insights on Financial Companies: American Express (NYSE: AXP) and Metlife (NYSE: MET)

Yaron Kinar

Mizuho Securities

$102

Buy

7.56%

Upside

Reiterated

07/13/26

Mizuho Securities Remains a Buy on Metlife (MET)

Ryan Krueger

KBW

$98→$105

Buy

10.72%

Upside

Reiterated

07/12/26

MetLife price target raised to $105 from $98 at Keefe BruyetteMetLife price target raised to $105 from $98 at Keefe Bruyette

Suneet Kamath

Jefferies

$103

Buy

8.62%

Upside

Reiterated

07/09/26

Jefferies Sticks to Its Buy Rating for Metlife (MET)

Elyse Greenspan

Wells Fargo

$95→$101

Buy

6.51%

Upside

Reiterated

07/09/26

Analysts' Opinions Are Mixed on These Financial Stocks: Nasdaq (NASDAQ: NDAQ), Saratoga Investment (NYSE: SAR) and Metlife (NYSE: MET)

Michael Ward CFA

UBS

$102→$105

Buy

10.72%

Upside

Assigned

07/08/26

UBS Sticks to Its Buy Rating for Metlife (MET)

Alex Scott

Barclays

$93→$94

Buy

-0.88%

Downside

Reiterated

07/07/26

Barclays Sticks to Their Buy Rating for Metlife (MET)

Bob Huang

Morgan Stanley

$93→$103

Buy

8.62%

Upside

Reiterated

07/06/26

MetLife price target raised to $103 from $93 at Morgan StanleyMetLife price target raised to $103 from $93 at Morgan Stanley

Unknown Analyst

Raymond James

Not Ranked

Raymond James

―

Hold

―

Reiterated

06/30/26

Metlife (MET) Receives a Hold from Raymond James

Paul Newsome

Piper Sandler

$86→$90

Hold

-5.09%

Downside

Reiterated

06/24/26

Metlife (MET) Gets a Hold from Piper Sandler

Thomas Gallagher

Evercore ISI

$95→$96

Hold

1.23%

Upside

Reiterated

04/09/26

MetLife price target raised to $96 from $95 at Evercore ISIMetLife price target raised to $96 from $95 at Evercore ISI

Kevin Heal

Argus Research

$90

Buy

-5.09%

Downside

Reiterated

12/08/25

MetLife's higher investment income supporting results, says ArgusMetLife's higher investment income supporting results, says Argus

Jack Matten

BMO Capital

$82→$84

Hold

-11.42%

Downside

Reiterated

09/30/25

BMO Capital Keeps Their Hold Rating on Metlife (MET)

Stocks with the Highest Top Analyst Consensus in the Financial Sector

PLMRPalomar Holdings

BPOPPopular

SPGIS&P Global

WULFTeraWulf Inc

BNBrookfield Corporation

Find stocks in the Financial sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Metlife

3 Months

Ryan KruegerKBW

Success Rate

23/34 ratings generated profit

Average Return

+7.14%

reiterated a buy rating 17 days ago

Copying Ryan Krueger's trades and holding each position for 3 Months would result in 67.65% of your transactions generating a profit, with an average return of +7.14% per trade.

1 Year

Ryan KruegerKBW

Success Rate

30/34 ratings generated profit

Average Return

+18.01%

reiterated a buy rating 17 days ago

Copying Ryan Krueger's trades and holding each position for 1 Year would result in 88.24% of your transactions generating a profit, with an average return of +18.01% per trade.

2 Years

Elyse GreenspanWells Fargo

Success Rate

31/31 ratings generated profit

Average Return

+25.51%

Copying Elyse Greenspan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +25.51% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MET Analyst Recommendation Trends

Rating

Mar 26

Apr 26

May 26

Jun 26

Jul 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, MET has received 34 Buy Ratings, 19 Hold Ratings, and 0 Sell Ratings. MET average Analyst price target in the past 3 months is 101.40.

Each month's total comprises the sum of three months' worth of ratings.

MET Financial Forecast

MET Earnings Forecast

Next quarter’s earnings estimate for MET is $2.29 with a range of $2.20 to $2.41. The previous quarter’s EPS was $2.42. MET beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 66.67% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.

MET Sales Forecast

Next quarter’s sales forecast for MET is $19.67B with a range of $18.91B to $20.47B. The previous quarter’s sales results were $19.07B. MET beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 100.00% of the time in the same period. In the last calendar year MET has Performed in-line its overall industry.

MET Stock Forecast FAQ

What is MET’s average 12-month price target, according to analysts?

Based on analyst ratings, Metlife’s 12-month average price target is 101.40.

What is MET’s upside potential, based on the analysts’ average price target?

Metlife has 6.93% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is MET a Buy, Sell or Hold?

Metlife has a consensus rating of Strong Buy which is based on 10 buy ratings, 2 hold ratings and 0 sell ratings.

What is Metlife’s price target?

The average price target for Metlife is 101.40. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $106.00 ,the lowest forecast is $90.00. The average price target represents 6.93% Increase from the current price of $94.83.

What do analysts say about Metlife?

Metlife’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of MET?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Metlife (MET) Stock Forecast & Price Target

MET Analyst Ratings

MET Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Metlife

MET Analyst Recommendation Trends

MET Financial Forecast

MET Earnings Forecast

MET Sales Forecast

MET Stock Forecast FAQ

Detailed List of Analyst Forecasts